ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.53
1.40%
US Tech 100
17,599.60
1.04%
S&P 500
5,180.74
1.03%
US Dollar vs CAD
1.36738
0.02%
Bitcoin
63,875.80
1.12%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LLY
DateTimeSourceHeadlineSymbolCompany
05/06/202410:32AMPR Newswire (US)Lilly Declares Second-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
04/30/20248:07AMIH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
04/30/20246:59AMIH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
04/30/20246:55AMIH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
04/30/20245:45AMPR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
04/17/20245:15AMPR Newswire (US)Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesityNYSE:LLYEli Lilly and Co
04/16/20249:00AMPR Newswire (US)Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementNYSE:LLYEli Lilly and Co
04/03/20246:12AMIH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:LLYEli Lilly and Co
03/11/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
03/11/20243:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
03/10/20243:00PMPR Newswire (US)More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab studyNYSE:LLYEli Lilly and Co
03/08/20245:45AMPR Newswire (US)U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of DonanemabNYSE:LLYEli Lilly and Co
03/07/20247:00AMPR Newswire (US)Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity CareNYSE:LLYEli Lilly and Co
03/05/20244:00PMPR Newswire (US)Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNYSE:LLYEli Lilly and Co
02/21/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/21/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/21/20243:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/21/20243:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/21/20243:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/20/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/20/20249:00AMPR Newswire (US)Lilly to Participate in Cowen's 44th Annual Health Care ConferenceNYSE:LLYEli Lilly and Co
02/16/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/15/20242:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
02/14/20243:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Your Recent History

USOTC
INKW
Greene Concepts (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
MVNT
Movement Industries (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
SFLM
SFLMaven (PK)
USOTC
TGLO
TheGlobe com (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
NASDAQ
MULN
Mullen Automotive
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
MGON
Megola (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
INND
Innerscope Hearing Techn... (PK)
USOTC
ALYI
Alternet Systems (PK)
USOTC
AFFU
Affluence (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ILST
International Star (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved